Tesamorelin Peptide Vial
Tesamorelin is a GHRH (growth hormone-releasing hormone) analogue that has been proven to increase IGF-1 and growth hormone levels. Currently, Tesamorelin is the most effective growth hormone on the market.
122 in stock
Tesamorelin Peptide Vial Europe
Tesamorelin peptide vial is a GHRH (growth hormone-releasing hormone) analogue that has been proven to increase IGF-1 and growth hormone levels. Currently, Tesamorelin is the most effective growth hormone on the market.
Benefits of Tesamorelin Europe
It binds as well as stimulates human growth hormone-releasing hormone receptors with the same potency as your own natural growth hormone-releasing hormone. Other benefits of Tesamorelin include decreased visceral fat tissue, reducing triglycerides, nootropic effects (better cognition), and reduced C-reactive protein, which is a marker of inflammation.
It stimulates the hypophysis in your brain to start secreting GH. Clinical trials have proven that Tesamorelin significantly decreases abdominal fat with very few side effects when compared to HGH itself. Also, it has been proven to decrease lipodystrophy syndromes in people infected with HIV.
In a placebo-controlled trial, Tesamorelin increases GH release and has been shown to improve several cognitive function measures in cognitively normal plus mildly impaired older people.
Also, in one study, scores on executive functions standard tests plus verbal memory were higher in participants who took Tesamorelin in a twenty-week trial.
Additionally, participants who were given Tesamorelin in the 78-person trial reported higher subjective improvement, specifically in cognition related to the placebo group.
In a current study, which was funded by the NIA (National Institute on Aging), 37 adults who have mild cognitive impairments and 41 cognitively normal adults were randomised to receive a placebo or Tesamorelin (1 milligram per day subcutaneously). Tesamorelin had a protective effect related to the placebo in cognitively impaired individuals.
At the final evaluation, the scores dipped an average of 5 points with the placebo, while the patients assigned to Tesamorelin appeared to have an average decline of just less than 1 point.
Dosage of Tesamorelin
Tesamorelin peptide vial should be taken based on the following factors:
- How you respond to the medication
- Other medications that you are taking
- medical conditions that you have
- The condition being treated
The recommended Tesamorelin dosage is 2 milligrams injected subcutaneously (directly under your skin) once a day.
|Dimensions||1 × 1 × 1 cm|